AIMS: To report the prevalence and correlates of affective and anxiety disorders, depressive affect and diabetes distress over time. METHODS: In a non-interventional study, 506 patients with Type 2 diabetes were assessed three times over 18 months (9-month intervals) for: major depressive disorder (MDD), general anxiety disorder (GAD), panic disorder (PANIC), dysthymia (DYS) (Composite International Diagnostic Interview); depressive affect [Center for Epidemiological Studies-Depression (CES-D)]; Diabetes Distress Scale (DDS); HbA(1c); and demographic data. RESULTS: Diabetic patients displayed high rates of affective and anxiety disorders over time, relative to community adults: 60% higher for MDD, 123% for GAD, 85% for PANIC, 7% for DYS. The prevalence of depressive affect and distress was 60-737% higher than of affective and anxiety disorders. The prevalence of individual patients with an affective and anxiety disorder over 18 months was double the rate assessed at any single wave. The increase for CES-D and DDS was about 60%. Persistence of CES-D and DDS disorders over time was significantly greater than persistence of affective and anxiety disorders, which tended to be episodic. Younger age, female gender and high comorbidities were related to persistence of all conditions over time. HbA(1c) was positively related to CES-D and DDS, but not to affective and anxiety disorders over time. CONCLUSIONS: The high prevalence of comorbid disorders and the persistence of depressive affect and diabetes distress over time highlight the need for both repeated mental health and diabetes distress screening at each patient contact, not just periodically, particularly for younger adults, women and those with complications/comorbidities.
AIMS: To report the prevalence and correlates of affective and anxiety disorders, depressive affect and diabetes distress over time. METHODS: In a non-interventional study, 506 patients with Type 2 diabetes were assessed three times over 18 months (9-month intervals) for: major depressive disorder (MDD), general anxiety disorder (GAD), panic disorder (PANIC), dysthymia (DYS) (Composite International Diagnostic Interview); depressive affect [Center for Epidemiological Studies-Depression (CES-D)]; Diabetes Distress Scale (DDS); HbA(1c); and demographic data. RESULTS:Diabeticpatients displayed high rates of affective and anxiety disorders over time, relative to community adults: 60% higher for MDD, 123% for GAD, 85% for PANIC, 7% for DYS. The prevalence of depressive affect and distress was 60-737% higher than of affective and anxiety disorders. The prevalence of individual patients with an affective and anxiety disorder over 18 months was double the rate assessed at any single wave. The increase for CES-D and DDS was about 60%. Persistence of CES-D and DDS disorders over time was significantly greater than persistence of affective and anxiety disorders, which tended to be episodic. Younger age, female gender and high comorbidities were related to persistence of all conditions over time. HbA(1c) was positively related to CES-D and DDS, but not to affective and anxiety disorders over time. CONCLUSIONS: The high prevalence of comorbid disorders and the persistence of depressive affect and diabetes distress over time highlight the need for both repeated mental health and diabetes distress screening at each patient contact, not just periodically, particularly for younger adults, women and those with complications/comorbidities.
Authors: Alexandre Y Dombrovski; Richard E Blakesley-Ball; Benoit H Mulsant; Sati Mazumdar; Patricia R Houck; Katalin Szanto; Charles F Reynolds Journal: Am J Geriatr Psychiatry Date: 2006-06 Impact factor: 4.105
Authors: Mark T Hegel; Jürgen Unützer; Lingqi Tang; Patricia A Areán; Wayne Katon; Polly Hitchcock Noël; John W Williams; Elizabeth H B Lin Journal: Am J Geriatr Psychiatry Date: 2005-01 Impact factor: 4.105
Authors: William H Polonsky; Lawrence Fisher; Jay Earles; R James Dudl; Joel Lees; Joseph Mullan; Richard A Jackson Journal: Diabetes Care Date: 2005-03 Impact factor: 19.112
Authors: Wayne J Katon; Carolyn Rutter; Greg Simon; Elizabeth H B Lin; Evette Ludman; Paul Ciechanowski; Leslie Kinder; Bessie Young; Michael Von Korff Journal: Diabetes Care Date: 2005-11 Impact factor: 19.112
Authors: Lawrence Fisher; Marilyn M Skaff; Joseph T Mullan; Patricia Arean; David Mohr; Umesh Masharani; Russell Glasgow; Grace Laurencin Journal: Diabetes Care Date: 2007-03 Impact factor: 19.112
Authors: K M Scott; R Bruffaerts; A Tsang; J Ormel; J Alonso; M C Angermeyer; C Benjet; E Bromet; G de Girolamo; R de Graaf; I Gasquet; O Gureje; J M Haro; Y He; R C Kessler; D Levinson; Z N Mneimneh; M A Oakley Browne; J Posada-Villa; D J Stein; T Takeshima; M Von Korff Journal: J Affect Disord Date: 2007-02-09 Impact factor: 4.839
Authors: Jayati Das-Munshi; Rob Stewart; Khalida Ismail; Paul E Bebbington; Rachel Jenkins; Martin J Prince Journal: Psychosom Med Date: 2007-07-16 Impact factor: 4.312
Authors: Melissa M Franks; Rachel C Hemphill; Amber J Seidel; Mary Ann Parris Stephens; Karen S Rook; James K Salem Journal: Aging Ment Health Date: 2012-04-26 Impact factor: 3.658
Authors: Lawrence Fisher; Danielle Hessler; William Polonsky; Lisa Strycker; Susan Guzman; Vicky Bowyer; Ian Blumer; Umesh Masharani Journal: Patient Educ Couns Date: 2017-07-08
Authors: Arthur R Andrews; Debbie Gomez; Austin Larey; Hayden Pacl; Dennis Burchette; Juventino Hernandez Rodriguez; Freddie A Pastrana; Ana J Bridges Journal: Fam Syst Health Date: 2016-09-26 Impact factor: 1.950
Authors: Michelle D Owens-Gary; Xuanping Zhang; Shawn Jawanda; Kai McKeever Bullard; Pamela Allweiss; Bryce D Smith Journal: J Gen Intern Med Date: 2018-10-22 Impact factor: 5.128